Ilex Medical Ltd (TLV:ILX)

Ilex Medical Income Statement

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	922.54	920.37	916.25	863.28	1,061	946.45
Revenue Growth (YoY)	-2.53%	0.45%	6.13%	-18.63%	12.10%	49.29%
Cost of Revenue	708.52	704.06	689.34	580.37	681.61	675.43
Gross Profit	214.02	216.31	226.9	282.91	379.38	271.02
Selling, General & Admin	143.77	143.77	142.6	132.77	126.84	117.95
Research & Development	7.43	7.62	6.85	5.89	8.35	8.42
Other Operating Expenses	1.77	2	-0.02	-2.1	-1.95	-1.86
Operating Expenses	152.97	153.38	149.42	136.56	133.24	124.51
Operating Income	61.05	62.93	77.48	146.35	246.14	146.51
Interest Expense	-3.48	-2.34	-1.78	-1.57	-1.97	-2.34
Interest & Investment Income	3.75	7.85	5.74	1.86	1.86	0.85
Earnings From Equity Investments	-8.33	-7.19	-4.01	-2.69	-0.26	-
Currency Exchange Gain (Loss)	0.66	0.22	-5.23	-10.27	-1.59	5.12
Other Non Operating Income (Expenses)	15.08	-3.74	-2.78	-9.84	7.4	3.94
EBT Excluding Unusual Items	68.73	57.73	69.43	123.85	251.58	154.07
Gain (Loss) on Sale of Investments	1.15	4.32	4.37	-2.72	3.78	0.09
Gain (Loss) on Sale of Assets	-0.46	-0.46	0.24	21.96	-0.01	-0.36
Pretax Income	69.43	61.6	74.04	143.09	255.35	153.8
Income Tax Expense	18.71	15.89	18.51	34.6	57.87	27.83
Earnings From Continuing Operations	50.72	45.7	55.53	108.49	197.48	125.97
Earnings From Discontinued Operations	-5.11	-6.72	-4.64	-6.37	-	-
Net Income to Company	45.61	38.98	50.89	102.12	197.48	125.97
Minority Interest in Earnings	-	-	-	-	-	-5.35
Net Income	45.61	38.98	50.89	102.12	197.48	120.62
Net Income to Common	45.61	38.98	50.89	102.12	197.48	120.62
Net Income Growth	-10.13%	-23.39%	-50.17%	-48.29%	63.72%	100.18%
Shares Outstanding (Basic)	-	11	11	11	11	11
Shares Outstanding (Diluted)	-	11	11	11	11	11
Shares Change (YoY)	-	-0.02%	-0.79%	-0.02%	5.73%	6.33%
EPS (Basic)	-	3.48	4.55	9.05	17.51	11.30
EPS (Diluted)	-	3.48	4.55	9.05	17.50	11.24
EPS Growth	-	-23.34%	-49.80%	-48.27%	55.66%	87.41%
Free Cash Flow	32.6	51.87	31.66	43.6	229.73	138.1
Free Cash Flow Per Share	-	4.64	2.83	3.87	20.36	12.94
Dividend Per Share	1.220	1.220	1.365	1.917	5.319	5.319
Dividend Growth	-10.63%	-10.63%	-28.80%	-63.97%	-	-
Gross Margin	23.20%	23.50%	24.76%	32.77%	35.76%	28.63%
Operating Margin	6.62%	6.84%	8.46%	16.95%	23.20%	15.48%
Profit Margin	4.94%	4.23%	5.55%	11.83%	18.61%	12.75%
Free Cash Flow Margin	3.53%	5.64%	3.46%	5.05%	21.65%	14.59%
EBITDA	95.15	96.72	111	196.39	296.63	186.4
EBITDA Margin	10.31%	10.51%	12.12%	22.75%	27.96%	19.70%
D&A For EBITDA	34.11	33.79	33.52	50.04	50.49	39.89
EBIT	61.05	62.93	77.48	146.35	246.14	146.51
EBIT Margin	6.62%	6.84%	8.46%	16.95%	23.20%	15.48%
Effective Tax Rate	26.95%	25.80%	25.00%	24.18%	22.66%	18.10%
Advertising Expenses	-	3.53	3.64	3.4	1.4	1.89

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.